Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous - a podcast by Pharma Talk Radio

from 2022-11-02T11:30

:: ::

In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities.

To learn more about the PODD Conference, please visit PODDConference.com.

 

Further episodes of PharmaTalkRadio

Further podcasts by Pharma Talk Radio

Website of Pharma Talk Radio